Akums Drugs and Pharmaceuticals gets SEBI’s nod for IPO

09 Jul 2024 Evaluate

Akums Drugs and Pharmaceuticals has received the Securities and Exchange Board of India (SEBI) go-ahead to raise funds through initial public offering (IPO). The initial share-sale is a combination of fresh issue of equity shares worth Rs 680 crore and an offer-for-sale (OFS) of 1.86 crore shares by promoters and an existing investor. The equity shares of the company will be listed on the BSE and NSE.

Proceeds from the fresh issue will be used to repay debt, fund working capital requirements of the company, pursue inorganic growth initiatives through acquisition and for general corporate purposes. ICICI Securities, Axis Capital, Citigroup Global Markets India and Ambit are the running lead managers to the issue. 

The company is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.


Akums Drugs & Pharma Share Price

471.20 -3.40 (-0.72%)
01-Apr-2025 09:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...